HK1094422A1 - Gastric retention system - Google Patents

Gastric retention system

Info

Publication number
HK1094422A1
HK1094422A1 HK07101362.1A HK07101362A HK1094422A1 HK 1094422 A1 HK1094422 A1 HK 1094422A1 HK 07101362 A HK07101362 A HK 07101362A HK 1094422 A1 HK1094422 A1 HK 1094422A1
Authority
HK
Hong Kong
Prior art keywords
retention system
gastric retention
gastric
retention
Prior art date
Application number
HK07101362.1A
Other languages
English (en)
Inventor
Nitin Bhalachandra Dharmadhikari
Yashoraj Rupsinh Zala
Original Assignee
Sun Pharma Advanced Res Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Res Co Ltd filed Critical Sun Pharma Advanced Res Co Ltd
Publication of HK1094422A1 publication Critical patent/HK1094422A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/003—Implantable devices or invasive measures inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/0036—Intragastrical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nursing (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07101362.1A 2004-03-25 2007-02-05 Gastric retention system HK1094422A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN364MU2004 2004-03-25
IN1058MU2004 2004-10-07
PCT/IN2005/000091 WO2005101983A2 (en) 2004-03-25 2005-03-24 Gastric retention system

Publications (1)

Publication Number Publication Date
HK1094422A1 true HK1094422A1 (en) 2007-03-30

Family

ID=35197425

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07101362.1A HK1094422A1 (en) 2004-03-25 2007-02-05 Gastric retention system

Country Status (22)

Country Link
US (1) US9439851B2 (ru)
EP (1) EP1732522B1 (ru)
JP (1) JP5166018B2 (ru)
KR (1) KR101147666B1 (ru)
CN (1) CN1960711A (ru)
AP (1) AP2006003751A0 (ru)
AR (1) AR048331A1 (ru)
AU (1) AU2005235239B2 (ru)
BR (1) BRPI0508744A (ru)
CA (1) CA2561109C (ru)
EA (1) EA011151B1 (ru)
ES (1) ES2389729T3 (ru)
HK (1) HK1094422A1 (ru)
IL (1) IL178054A (ru)
MA (1) MA28542B1 (ru)
MX (1) MXPA06010678A (ru)
MY (1) MY148867A (ru)
NZ (1) NZ549853A (ru)
PE (1) PE20061160A1 (ru)
PL (1) PL1732522T3 (ru)
TW (1) TW200533391A (ru)
WO (1) WO2005101983A2 (ru)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785291B2 (en) 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7699863B2 (en) 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
MX2008002795A (es) * 2005-08-30 2009-02-25 Nicholas Piramal India Ltd Composicion farmaceutica de metformina de liberacion extendida y proceso para producirla.
US7674396B2 (en) * 2005-11-08 2010-03-09 Plensat Llc Method and system for treatment of eating disorders
AU2007201808B8 (en) * 2006-04-26 2013-09-05 Sun Pharmaceutical Advanced Research Company Ltd A method for alleviating signs and symptoms of spasticity
EP2032093B1 (en) 2006-05-18 2013-09-04 Tulip Medical Ltd. Bioerodible intragastric implant
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
EP2066303B1 (en) * 2006-09-26 2016-05-04 Plensat, LLC System for treatment of eating disorders
US20100081672A1 (en) * 2006-12-07 2010-04-01 Schering Corporation Ph sensitive matrix formulation
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
CA2694602A1 (en) * 2007-07-27 2009-02-05 Depomed, Inc. Pulsatile gastric retentive dosage forms
WO2009022358A1 (en) * 2007-08-10 2009-02-19 Luigi Ambrosio Superabsorbent polymer hydro gels and a method of preparing thereof
US20110171275A1 (en) * 2007-08-20 2011-07-14 Team Academy Of Pharmaceutical Science Gastroretentive drug delivery system, preparation method and use thereof
MX340249B (es) 2008-08-15 2016-07-01 Depomed Inc Composiciones farmacéuticas retentivas gástricas para tratamiento y prevención de transtornos del sistema nervioso central (cns).
KR20110042366A (ko) * 2008-08-18 2011-04-26 팀 아카데미 오브 파마슈티컬 사이언스 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용
FR2938431B1 (fr) 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
WO2011101866A2 (en) 2010-02-17 2011-08-25 Sun Pharma Advanced Research Company Ltd., A method of treating a disease condition susceptible to baclofen therapy
EP2389933A1 (en) * 2010-05-25 2011-11-30 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-Release Pregabalin Compositions
ES2716550T3 (es) * 2010-08-18 2019-06-13 Evonik Roehm Gmbh Formulación farmacéutica o nutracéutica gastrorresistente que comprende una o más sales de ácido algínico
EP2826469A1 (en) 2010-12-22 2015-01-21 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
CA2822769C (en) 2010-12-23 2016-10-04 Purdue Pharma L.P. Tamper resistant solid oral dosage forms
US20130017264A1 (en) * 2011-07-15 2013-01-17 Piramal Life Sciences Limited Alginate tube drug delivery system and method therefor
AU2012322323B2 (en) * 2011-10-11 2016-04-21 Sun Pharmaceutical Industries Limited A gastroretentive dosage system and process of preparation thereof
DK2858604T3 (da) * 2012-06-07 2024-05-21 Epitomee Medical Ltd Ekspanderet anordning
AU2012388440B2 (en) 2012-08-27 2017-08-31 Evonik Operations Gmbh Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
SI2887926T1 (sl) * 2012-08-27 2016-12-30 Evonik Roehm Gmbh Farmacevtski ali nutracevtski sestavek z lastnostmi zadržanega sproščanja in z odpornostjo na vpliv etanola
EP2953618B1 (en) 2013-02-05 2020-11-11 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
JP2017502935A (ja) * 2013-12-05 2017-01-26 チューリップ メディカル リミテッド 薬剤の活性剤をｉｎ−ｓｉｔｕ放出させるための滞留装置及びシステム
WO2015121189A1 (en) * 2014-02-17 2015-08-20 Evonik Industries Ag Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
KR101642193B1 (ko) * 2014-10-13 2016-07-25 씨제이헬스케어 주식회사 메트포르민 서방성 제제 및 그의 제조방법
EP3025709B1 (en) * 2014-11-27 2020-09-30 Capsugel Belgium NV Dosage form articles for external mucosal applications
WO2016193034A1 (en) 2015-06-05 2016-12-08 Evonik Röhm Gmbh Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
EP3167879A1 (en) 2015-11-10 2017-05-17 Evonik Technochemie GmbH Gastric retention active delivery systems
WO2018102799A1 (en) * 2016-12-02 2018-06-07 Clexio Biosciences Ltd. Gastric residence system
IL250090B (en) 2017-01-12 2018-10-31 Melcap Systems Ltd A capsule is intended for ingestion by a subject and a system is intended for the digestive system
JP6823539B2 (ja) * 2017-05-26 2021-02-03 株式会社ファンケル 胃内滞留性錠剤
CN110996922A (zh) * 2017-06-16 2020-04-10 卡希夫生物科学有限责任公司 用于持续药物递送的胃滞留剂型
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
FR3068039B1 (fr) 2017-06-22 2020-07-10 Jellynov Composition auto-moussante en milieu acide et procede de preparation
WO2019022982A1 (en) 2017-07-26 2019-01-31 Verily Life Sciences Llc INGREDIENT INTRAGASTRIC BALLOON
AU2018388577B2 (en) 2017-12-18 2024-06-06 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
WO2019126214A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
EP3737353A1 (en) 2017-12-18 2020-11-18 Tris Pharma, Inc. Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
TW201929839A (zh) * 2017-12-29 2019-08-01 大陸商江蘇恒瑞醫藥股份有限公司 一種控釋藥物組合物及其製備方法
CN112118886B (zh) 2018-05-23 2022-08-23 上海汉都医药科技有限公司 活性药物成分的控释系统及其制备方法
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
ES2912968T3 (es) 2018-06-18 2022-05-30 Amneal Complex Products Res Llc Composiciones de liberación prolongada que comprenden piridostigmina
FR3089224B1 (fr) * 2018-12-04 2020-12-11 Jellynov Composition auto-moussante en milieu acide et procédé de préparation
EP3968980A1 (en) 2019-05-14 2022-03-23 Clexio Biosciences Ltd. Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
CN113116842A (zh) * 2019-12-31 2021-07-16 广州玻思韬控释药业有限公司 胃滞留片
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3786813A (en) 1972-12-27 1974-01-22 Alza Corp Drug delivery device with self actuated mechanism for retaining device in selected area
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4101650A (en) 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
DE3681348D1 (de) 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
JPS62195323A (ja) 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
JPH0747534B2 (ja) 1986-06-02 1995-05-24 ロ−ラ−ジヤパン株式会社 錠 剤
IL87710A (en) 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US5783212A (en) 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
JP3825811B2 (ja) 1997-01-14 2006-09-27 エルティエス ローマン テラピー−ズュステーメ アーゲー 胃腸系での活性物質の制御放出を用いた膨張性胃内貯留治療システム
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (ru) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
DE19822278A1 (de) 1998-05-18 1999-12-02 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoff im Gastrointestinaltrakt mit verzögerter Pyloruspassage
FR2784583B1 (fr) 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
DE19850309A1 (de) 1998-10-30 2000-05-04 Lohmann Therapie Syst Lts Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer
NZ513037A (en) * 1999-01-29 2003-05-30 Disphar Internat B Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract
AU5060499A (en) 1999-08-04 2001-03-05 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system
FR2797185B1 (fr) 1999-08-06 2001-10-26 Galenix Dev Composition pharmaceutique flottante comprenant une phase active et une phase non active
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
MXPA02012793A (es) * 2000-06-23 2004-07-30 Teva Pharmaceuticals Ltd Composicion de dilatacion rapida para la retencion gastrica y la liberacion controlada de agentes terapeuticos y formas de dosificacion de la composicion.
US20030008007A1 (en) 2001-04-23 2003-01-09 Jose Gutierrez-Rocca Release pharmaceutical construct for gastric retention
PL370793A1 (en) * 2001-07-04 2005-05-30 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
EP1416919A1 (en) * 2001-07-17 2004-05-12 Teva Pharmaceutical Industries Ltd. Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate
IN191024B (ru) * 2001-09-25 2003-09-13 J B Chemicals And Pharmaceutic
EP1509208A1 (en) 2002-02-04 2005-03-02 Ranbaxy Laboratories Limited Hydrodynamically balancing oral drug delivery system with biphasic release
JP2003306428A (ja) 2002-04-17 2003-10-28 Zensei Yakuhin Kogyo Kk 服用性を改善した硬カプセル剤
KR20050083750A (ko) * 2002-10-11 2005-08-26 디포메드 디벨롭먼트 리미티드 위-체류성 레보도파 전달 형태

Also Published As

Publication number Publication date
NZ549853A (en) 2009-12-24
PE20061160A1 (es) 2006-11-12
AU2005235239A1 (en) 2005-11-03
IL178054A (en) 2013-11-28
MA28542B1 (fr) 2007-04-03
AR048331A1 (es) 2006-04-19
CA2561109A1 (en) 2005-11-03
TW200533391A (en) 2005-10-16
US9439851B2 (en) 2016-09-13
JP2007530530A (ja) 2007-11-01
KR20060126611A (ko) 2006-12-07
EA011151B1 (ru) 2009-02-27
PL1732522T3 (pl) 2012-12-31
US20080107732A1 (en) 2008-05-08
AP2006003751A0 (en) 2006-10-31
CA2561109C (en) 2012-09-18
BRPI0508744A (pt) 2007-08-14
IL178054A0 (en) 2006-12-31
WO2005101983A3 (en) 2006-04-27
JP5166018B2 (ja) 2013-03-21
KR101147666B1 (ko) 2012-05-22
CN1960711A (zh) 2007-05-09
EA200601771A1 (ru) 2007-02-27
MY148867A (en) 2013-06-14
AU2005235239B2 (en) 2011-06-23
MXPA06010678A (es) 2006-12-15
WO2005101983A2 (en) 2005-11-03
EP1732522A2 (en) 2006-12-20
ES2389729T3 (es) 2012-10-30
EP1732522B1 (en) 2012-07-04

Similar Documents

Publication Publication Date Title
AP2006003751A0 (en) Gastric retention system
GB0502159D0 (en) Videoendoscopic system
EP1708407A4 (en) MixNet SYSTEM
EP1745235A4 (en) CONNECTING SYSTEM
IL183862A0 (en) System
GB0412796D0 (en) Supawall system
GB2420200B (en) Memory system
EP1800085A4 (en) DELIVERY SYSTEM
EP1814057A4 (en) AUTHENTICATION SYSTEM
GB0416731D0 (en) Location system
GB2410560B (en) System
EP1807810A4 (en) CASH HANDLING SYSTEM
GB0622917D0 (en) Deployment system
GB0416353D0 (en) On-cart-data-collection system (OCDCS)
GB0426162D0 (en) Ignition system
GB0428296D0 (en) Reflector system
GB0416478D0 (en) Positioning system
GB0514898D0 (en) Introduction system
GB0409627D0 (en) Fabron fabloc system
GB2408130B (en) Phonecard system
GB0421161D0 (en) X-plug system
GB0418526D0 (en) Nu-break system
GB0404063D0 (en) Slotdrain system
GB0403317D0 (en) System
HU0400134V0 (en) Clothing-dryer system

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170324